RecruitingNCT01503190

The Immune System's Response to Young Women's Breast Cancer

A Translational Study of the Interactions Between Prior Pregnancy and the Biologic Subtype of Breast Cancer in Defining the Cancer: Host Immunologic Interaction


Sponsor

University of Colorado, Denver

Enrollment

800 participants

Start Date

Jul 21, 2009

Study Type

OBSERVATIONAL

Conditions

Summary

This study plans to learn more about the immune system's response to breast cancer in young women.


Eligibility

Sex: FEMALEMin Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is investigating how the immune system responds to breast cancer in younger women, by analyzing tumor tissue and blood samples to look for patterns that could predict treatment outcomes and guide better therapies. **You may be eligible if...** - You are a woman over 18 years old - You have been diagnosed with breast cancer (confirmed by lab testing) - Tumor tissue samples are available or will be available from your biopsy or surgery - You are willing to have fresh tissue collected during your procedure **You may NOT be eligible if...** - You are unwilling to have tissue samples collected - You are unable to provide informed consent - Tumor tissue is not available and cannot be collected Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(5)

University of Colorado Denver

Aurora, Colorado, United States

Denver Health Hospital Authority

Denver, Colorado, United States

UCHealth Cherry Creek Medcial Center

Denver, Colorado, United States

UCHealth Highlands Ranch Hospital

Highlands Ranch, Colorado, United States

UCHealth Lone Tree Medical Center

Lone Tree, Colorado, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT01503190


Related Trials